Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

The FDA grants orphan drug designation to Bone Therapeutics' bone marrow derived cells

Nov. 16, 2015

World Diabetes Day: testing the tissue engineering approach

Nov. 13, 2015

Mechanism of obesity associated with BDNF SNP

Nov. 13, 2015

Mitsubishi Tanabe Pharma patents CYP11B2 inhibitors

Nov. 12, 2015

MedImmune initiates first-in-human study of MEDI-4166 for type 2 diabetes

Nov. 12, 2015

WuXi PharmaTech and Lilly to codevelop drug for patients with dyslipidemia in China

Nov. 11, 2015

CymaBay Therapeutics confirms initiation of phase II study of MBX-8025

Nov. 11, 2015

Janssen licenses rights to Hanmi's oxyntomodulin-based therapies

Nov. 10, 2015

PhaseBio begins phase IIa study of once-weekly basal insulin, PE0-139

Nov. 10, 2015

FDA accepts for review Amgen's NDA for etelcalcetide

Nov. 9, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...